|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002170,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0024554,
umls-concept:C0034656,
umls-concept:C0060389,
umls-concept:C0087111,
umls-concept:C0449774,
umls-concept:C0599724,
umls-concept:C0754659,
umls-concept:C1274040,
umls-concept:C1554184,
umls-concept:C2252854
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-11-19
|
|
pubmed:abstractText |
Male pattern hair loss (MPHL) is a potentially reversible condition in which dihydrotestosterone is an important etiologic factor.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1097-6787
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1014-23
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17110217-5-alpha Reductase Inhibitors,
pubmed-meshheading:17110217-Adult,
pubmed-meshheading:17110217-Alopecia,
pubmed-meshheading:17110217-Androgen Antagonists,
pubmed-meshheading:17110217-Azasteroids,
pubmed-meshheading:17110217-Dihydrotestosterone,
pubmed-meshheading:17110217-Dose-Response Relationship, Drug,
pubmed-meshheading:17110217-Finasteride,
pubmed-meshheading:17110217-Hair,
pubmed-meshheading:17110217-Humans,
pubmed-meshheading:17110217-Isoenzymes,
pubmed-meshheading:17110217-Libido,
pubmed-meshheading:17110217-Male,
pubmed-meshheading:17110217-Middle Aged,
pubmed-meshheading:17110217-Scalp,
pubmed-meshheading:17110217-Testosterone,
pubmed-meshheading:17110217-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
|
|
pubmed:affiliation |
Duke University Medical Center, Durham, North Carolina, USA. olsen001@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
